BOTOX 100 Allergan Units Powder for Solution for Injection
Sponsors
Abbvie Deutschland GmbH & Co. KG, Ospedale San Raffaele S.r.l., University Of Antwerp, Algemeen Ziekenhuis Delta, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Conditions
Adult patientsMasseter Muscle ProminencePost-surgical scar painRectal CancerSpasticity after Strokemale or femalepostoperative pancreatic fistulasretrograde cricopharyngeus dysfunction
Phase 1
Phase 2
Comparative study of the mechanism of action of Dry Needling and Botulinum Toxin type A as a treatment for lower limb post-stroke spasticity: a proof of concept controlled trial
RecruitingCTIS2024-510866-18-00
Start: 2025-02-21Target: 60Updated: 2025-02-26
Colonic Intramural Injections of Botulin toxin versus placebo to treat fragmented defecation and urgency after restorative total mesorectal excision (TME) for rectal cancer
Not yet recruitingCTIS2025-524342-96-00
Target: 20Updated: 2026-04-02
Phase 3
BOTOX® (Botulinum toxin type A) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
CompletedCTIS2022-500568-37-00
Start: 2023-10-11End: 2025-10-29Target: 199Updated: 2025-11-20
Botulinumtoxin type A for treatment of Chronic Pelvic Pain Syndrome (CPPS): a phase 3 randomized, double blind, placebo-controlled, multi-center study
Not yet recruitingCTIS2023-506372-27-00
Target: 110Updated: 2025-11-04
Phase 4
Botulinum toxin injection in the upper esophageal sphincter for retrograde-cricopharyngeus dysfunction: a double blind, placebo-controlled trial.
RecruitingCTIS2024-512546-42-00
Start: 2024-09-02Target: 44Updated: 2025-06-13
Efficacy of botulinum toxin vs corticosteroid in the management of persistent post-surgical scar pain
Not yet recruitingCTIS2024-518954-18-01
Target: 60Updated: 2024-12-05